Drawing attention to ending gender-based violence

NewsGuard 100/100 Score

A post in the U.S. Department of State's "DipNote" blog highlights the International Day for the Elimination of Violence Against Women, commemorated on November 25, and the 16 Days Campaign Against Gender-Based Violence. The blog recaps a video message from Ambassador-at-Large for Global Women's Issues Melanne Verveer and writes, "In the weeks ahead, U.S. embassies and others will be drawing public attention to the need to end gender-based violence. As Ambassador Verveer says, 'The International Day for the Elimination of Violence Against Women and the 16 Days Campaign Against Gender-Based Violence offer an opportunity to renew the commitment to free women and girls from the nightmare of violence, whether the abuse occurs in the home behind closed doors, or in the open fields of armed conflict." The blog includes links to statements by Vice President Joe Biden and Secretary of State Hillary Clinton (11/25).


    http://www.kaiserhealthnews.orgThis article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

    Comments

    The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
    Post a new comment
    Post

    While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

    Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

    Please do not ask questions that use sensitive or confidential information.

    Read the full Terms & Conditions.